Skip to main content

Advertisement

Fig. 5 | Cancer Communications

Fig. 5

From: Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo

Fig. 5

Azithromycin increases the expression of the death receptor proteins. a HCT-116 and SW480 cells were treated with azithromycin for the indicated times. b Cells were treated with various concentrations of azithromycin for 10 h. The expression levels of proteins were determined using Western blot analysis. The data are shown as the mean ± SD of three independent samples. AZM represents azithromycin

Back to article page